Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron ...

Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information.

However, today, Bank of America Securities maintained a Sell rating on Regeneron (NASDAQ: REGN). Based on Regeneron’s latest earnings release for the quarter ending December 31, the company ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labour and TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...

IST, the barometer index, the S&P BSE Sensex, surged 1,626.54 points or 2.16% to 76,777.53. The Nifty 50 index rallied 498.25 points or 2.18% to 23,326.80.

“This settlement clears the path for Biocon Biologics to be among the first to bring a reliable, high-quality aflibercept biosimilar to patients and healthcare providers in the U.S.,” said Shreehas ...

Mark Cuban addressed President Donald Trump's tariff exemption strategy on electronics, suggesting it could generate billions ...